Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshitaka Inaba

Showing results (121-130 of 156) with videos related to

Pageof 16
Sort By:
Journal of Vascular and Interventional Radiology : JVIR|June 22, 2024
Radiofrequency Ablation in Patients with Interstitial Lung Disease and Lung Neoplasm: A Retrospective Multicenter StudyAkira Yamamoto, Takao Hiraki, Osamu Ikeda, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 5, 2023
Cabozantinib in Japanese patients with advanced hepatocellular carcinoma: Final results of a multicenter phase II studyNaoya Kato, Masatoshi Kudo, Kaoru Tsuchiya, et al.
Journal of Clinical Medicine|October 12, 2019
Prognostic Significance of Sarcopenia in Patients with Unresectable Advanced Esophageal CancerSachiyo Onishi, Masahiro Tajika, Tsutomu Tanaka, et al.
Journal of Vascular and Interventional Radiology : JVIR|August 28, 2012
Phase I/II study of radiologic hepatic arterial infusion of fluorouracil plus systemic irinotecan for unresectable hepatic metastases from colorectal cancer: Japan Clinical Oncology Group Trial 0208-DIYasuaki Arai, Atsushi Ohtsu, Yozo Sato, et al.
Investigational New Drugs|December 22, 2010
Phase II study of combination chemotherapy with biweekly cetuximab and irinotecan for wild-type KRAS metastatic colorectal cancer refractory to irinotecan, oxaliplatin, and fluoropyrimidinesKohei Shitara, Satoshi Yuki, Motoki Yoshida, et al.
Medicine|June 1, 2017
Acute hyperammonemic encephalopathy after fluoropyrimidine-based chemotherapy: A case series and review of the literatureSeiichiro Mitani, Shigenori Kadowaki, Azusa Komori, et al.
Liver Cancer|September 26, 2022
Clinical Practice Guidelines for Hepatic Arterial Infusion Chemotherapy with a Port System Proposed by the Japanese Society of Interventional Radiology and Japanese Society of Implantable Port Assisted TreatmentKazuomi Ueshima, Atsushi Komemushi, Takeshi Aramaki, et al.
Journal of Gastroenterology|January 4, 2021
Cabozantinib in Japanese patients with advanced hepatocellular carcinoma: a phase 2 multicenter studyMasatoshi Kudo, Kaoru Tsuchiya, Naoya Kato, et al.
Oncology|November 8, 2011
Prolonged survival of patients with metastatic colorectal cancer following first-line oxaliplatin-based chemotherapy with molecular targeting agents and curative surgeryKohei Shitara, Keitaro Matsuo, Chihiro Kondo, et al.
Investigational New Drugs|January 15, 2010
Phase II study of combination chemotherapy with irinotecan and cetuximab for pretreated metastatic colorectal cancer harboring wild-type KRASKohei Shitara, Tomoya Yokota, Daisuke Takahari, et al.
Pageof 16

Showing results (121-130 of 156) with videos related to

Sort By:
Pageof 16
Journal of Vascular and Interventional Radiology : JVIR|June 22, 2024
Radiofrequency Ablation in Patients with Interstitial Lung Disease and Lung Neoplasm: A Retrospective Multicenter StudyAkira Yamamoto, Takao Hiraki, Osamu Ikeda, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 5, 2023
Cabozantinib in Japanese patients with advanced hepatocellular carcinoma: Final results of a multicenter phase II studyNaoya Kato, Masatoshi Kudo, Kaoru Tsuchiya, et al.
Journal of Clinical Medicine|October 12, 2019
Prognostic Significance of Sarcopenia in Patients with Unresectable Advanced Esophageal CancerSachiyo Onishi, Masahiro Tajika, Tsutomu Tanaka, et al.
Journal of Vascular and Interventional Radiology : JVIR|August 28, 2012
Phase I/II study of radiologic hepatic arterial infusion of fluorouracil plus systemic irinotecan for unresectable hepatic metastases from colorectal cancer: Japan Clinical Oncology Group Trial 0208-DIYasuaki Arai, Atsushi Ohtsu, Yozo Sato, et al.
Investigational New Drugs|December 22, 2010
Phase II study of combination chemotherapy with biweekly cetuximab and irinotecan for wild-type KRAS metastatic colorectal cancer refractory to irinotecan, oxaliplatin, and fluoropyrimidinesKohei Shitara, Satoshi Yuki, Motoki Yoshida, et al.
Medicine|June 1, 2017
Acute hyperammonemic encephalopathy after fluoropyrimidine-based chemotherapy: A case series and review of the literatureSeiichiro Mitani, Shigenori Kadowaki, Azusa Komori, et al.
Liver Cancer|September 26, 2022
Clinical Practice Guidelines for Hepatic Arterial Infusion Chemotherapy with a Port System Proposed by the Japanese Society of Interventional Radiology and Japanese Society of Implantable Port Assisted TreatmentKazuomi Ueshima, Atsushi Komemushi, Takeshi Aramaki, et al.
Journal of Gastroenterology|January 4, 2021
Cabozantinib in Japanese patients with advanced hepatocellular carcinoma: a phase 2 multicenter studyMasatoshi Kudo, Kaoru Tsuchiya, Naoya Kato, et al.
Oncology|November 8, 2011
Prolonged survival of patients with metastatic colorectal cancer following first-line oxaliplatin-based chemotherapy with molecular targeting agents and curative surgeryKohei Shitara, Keitaro Matsuo, Chihiro Kondo, et al.
Investigational New Drugs|January 15, 2010
Phase II study of combination chemotherapy with irinotecan and cetuximab for pretreated metastatic colorectal cancer harboring wild-type KRASKohei Shitara, Tomoya Yokota, Daisuke Takahari, et al.
Pageof 16